Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 57.35B | 52.51B | 44.36B | 38.65B | 36.25B | 31.82B |
Gross Profit | 28.68B | 52.51B | 44.34B | 38.65B | 36.25B | 31.82B |
EBITDA | -834.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | 2.35B | 4.20B | 2.49B | 2.95B | 5.64B | 196.00M |
Balance Sheet | ||||||
Total Assets | 1.59T | 1.57T | 1.55T | 1.49T | 1.46T | 1.46T |
Cash, Cash Equivalents and Short-Term Investments | 217.73B | 317.62B | 327.40B | 207.01B | 284.55B | 245.79B |
Total Debt | 182.41B | 0.00 | 179.81B | 155.43B | 153.47B | 155.33B |
Total Liabilities | 182.41B | 1.49T | 1.48T | 1.41T | 1.39T | 1.39T |
Stockholders Equity | 67.34B | 70.26B | 65.97B | 66.45B | 65.07B | 61.68B |
Cash Flow | ||||||
Free Cash Flow | 12.22B | -21.53B | 25.56B | 29.50B | 13.83B | 75.20B |
Operating Cash Flow | 25.16B | -10.10B | 37.42B | 39.09B | 20.29B | 80.79B |
Investing Cash Flow | -13.56B | -13.74B | -12.07B | -9.01B | -10.12B | -6.86B |
Financing Cash Flow | -4.22B | -1.27B | -3.90B | -214.00M | -3.63B | 2.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $28.50B | 13.30 | 11.58% | 3.47% | 2.08% | 2.87% | |
77 Outperform | $40.85B | 12.43 | 6.00% | 0.19% | -6.42% | 117.22% | |
76 Outperform | $31.09B | 12.69 | 9.48% | 2.79% | 0.62% | 14.75% | |
74 Outperform | $64.57B | 9.18 | 20.65% | 0.96% | -6.74% | 5.13% | |
72 Outperform | $62.95B | 13.39 | 10.06% | 1.04% | 3.47% | -8.90% | |
69 Neutral | $59.56B | 12.47 | 8.13% | 4.56% | 18.25% | ― | |
68 Neutral | ¥760.77B | 10.93 | 7.55% | 3.20% | 7.81% | 14.63% |